Report for Shrikhande A

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (7)

Title : A novel series of [3.2.1] azabicyclic biaryl ethers as alpha3beta4 and alpha6\/4beta4 nicotinic receptor agonists - Lowe_2010_Bioorg.Med.Chem.Lett_20_4749
Author(s) : Lowe JA, 3rd , DeNinno SL , Coe JW , Zhang L , Mente S , Hurst RS , Mather RJ , Ward KM , Shrikhande A , Rollema H , Johnson DE , Horner W , Gorczyca R , Tingley FD, 3rd , Kozak R , Majchrzak MJ , Tritto T , Sadlier J , Shaffer CL , Ellerbrock B , Osgood SM , MacDougall MC , McDowell LL
Ref : Bioorganic & Medicinal Chemistry Lett , 20 :4749 , 2010
Abstract : Lowe_2010_Bioorg.Med.Chem.Lett_20_4749
ESTHER : Lowe_2010_Bioorg.Med.Chem.Lett_20_4749
PubMedSearch : Lowe_2010_Bioorg.Med.Chem.Lett_20_4749
PubMedID: 20663668

Title : Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence - Rollema_2010_Br.J.Pharmacol_160_334
Author(s) : Rollema H , Shrikhande A , Ward KM , Tingley FD, 3rd , Coe JW , O'Neill BT , Tseng E , Wang EQ , Mather RJ , Hurst RS , Williams KE , De Vries M , Cremers T , Bertrand S , Bertrand D
Ref : British Journal of Pharmacology , 160 :334 , 2010
Abstract : Rollema_2010_Br.J.Pharmacol_160_334
ESTHER : Rollema_2010_Br.J.Pharmacol_160_334
PubMedSearch : Rollema_2010_Br.J.Pharmacol_160_334
PubMedID: 20331614

Title : Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists - O'Donnell_2009_Bioorg.Med.Chem.Lett_19_4747
Author(s) : O'Donnell CJ , Peng L , O'Neill BT , Arnold EP , Mather RJ , Sands SB , Shrikhande A , Lebel LA , Spracklin DK , Nedza FM
Ref : Bioorganic & Medicinal Chemistry Lett , 19 :4747 , 2009
Abstract : O'Donnell_2009_Bioorg.Med.Chem.Lett_19_4747
ESTHER : O'Donnell_2009_Bioorg.Med.Chem.Lett_19_4747
PubMedSearch : O'Donnell_2009_Bioorg.Med.Chem.Lett_19_4747
PubMedID: 19576766

Title : Poster: Preclinical properties of the alpha4\/beta2 nAChR partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence -
Author(s) : Rollema H , Shrikhande A , Ward KM , Coe JW , Tseng E , Wang EQ , De Vries M , Cremers THIF , Bertrand S , Bertrand D
Ref : Biochemical Pharmacology , 78 :918 , 2009
PubMedID:

Title : Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect - Rollema_2009_Eur.J.Pharmacol_605_114
Author(s) : Rollema H , Guanowsky V , Mineur YS , Shrikhande A , Coe JW , Seymour PA , Picciotto MR
Ref : European Journal of Pharmacology , 605 :114 , 2009
Abstract : Rollema_2009_Eur.J.Pharmacol_605_114
ESTHER : Rollema_2009_Eur.J.Pharmacol_605_114
PubMedSearch : Rollema_2009_Eur.J.Pharmacol_605_114
PubMedID: 19168054

Title : Poster: Low efficacy partial agonists of the alpha4\/beta2 nicotinic acetylcholine receptor (nAChR). Does functional efficacy govern in vivo response? -
Author(s) : Coe JW , Brooks PR , Wirtz MC , Vetelino MG , Arnold EP , Sands SB , Davis TI , Lebel LA , Fox CB , Shrikhande A , Mansbach RS , Chambers LK , Rovetti CC , Schulz DW , Tingley Iii FD , ONeill BT , Rollema H
Ref : Biochemical Pharmacology , 78 :919 , 2009
PubMedID:

Title : Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation - Coe_2005_J.Med.Chem_48_3474
Author(s) : Coe JW , Brooks PR , Vetelino MG , Wirtz MC , Arnold EP , Huang J , Sands SB , Davis TI , Lebel LA , Fox CB , Shrikhande A , Heym JH , Schaeffer E , Rollema H , Lu Y , Mansbach RS , Chambers LK , Rovetti CC , Schulz DW , Tingley FD, 3rd , O'Neill BT
Ref : Journal of Medicinal Chemistry , 48 :3474 , 2005
Abstract : Coe_2005_J.Med.Chem_48_3474
ESTHER : Coe_2005_J.Med.Chem_48_3474
PubMedSearch : Coe_2005_J.Med.Chem_48_3474
PubMedID: 15887955